Edition:
United Kingdom

Kazia Therapeutics Ltd (KZIA.OQ)

KZIA.OQ on NASDAQ Stock Exchange Capital Market

5.12USD
23 May 2018
Change (% chg)

$-0.05 (-0.97%)
Prev Close
$5.17
Open
$5.12
Day's High
$5.12
Day's Low
$5.12
Volume
189
Avg. Vol
5,725
52-wk High
$6.64
52-wk Low
$2.28

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec 0.07 0.009
FY 2017 Jun '17 0.11 -0.134
Dec 0.14 -0.092
FY 2016 Jun '16 0.24 -0.192
Dec 0.17 -0.090
 
*Note: Units in Millions ofAustralian Dollars
**Note: Units in Australian Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Jun-18 1 4.04 4.04 4.04 0.00
Year Ending Jun-19 1 13.96 13.96 13.96 --
Earnings (per share)
Year Ending Jun-18 1 -259.59 -259.59 -259.59 -12.00
Year Ending Jun-19 1 -134.36 -134.36 -134.36 -16.00
Sales and Profit Figures in Australian Dollar (AUD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 84.06 32.75
P/E High - Last 5 Yrs. -- 293.32 45.73
P/E Low - Last 5 Yrs. -- 91.63 24.23
Beta -0.08 0.90 0.88
Price to Sales (TTM) 79.63 110.95 5.71
Price to Book (MRQ) 0.18 13.58 5.37
Price to Tangible Book (MRQ) 2.10 14.04 6.94
Price to Cash Flow (TTM) -- 71.44 23.33
% Owned Institutions 1.59 12.71 2.16

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.51
Dividend 5 Year Growth Rate -- 1.66 5.32
Payout Ratio(TTM) -- 15.72 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -55.57 399.27 9.21
Sales (TTM) vs TTM 1 Yr. Ago -38.66 78.86 5.69
Sales - 5 Yr. Growth Rate -29.68 32.18 10.32
EPS (MRQ) vs Qtr. 1 Yr. Ago 82.47 25.14 19.38
EPS (TTM) vs TTM 1 Yr. Ago 55.28 -- --
EPS - 5 Yr. Growth Rate -- 39.01 10.77
Capital Spending - 5 Yr. Growth Rate 63.40 40.31 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.81 2.19
Current Ratio (MRQ) 3.62 5.29 2.98
LT Debt to Equity (MRQ) 0.00 22.98 12.17
Total Debt to Equity (MRQ) 0.00 24.63 16.44
Interest Coverage (TTM) -381,217.00 -99.39 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.04 54.45
Gross Margin - 5 Yr. Avg. -- 51.16 52.21
EBITD Margin (TTM) -6,924.99 -- --
EBITD - 5 Yr. Avg -2,506.94 -575.09 10.96
Operating Margin (TTM) -7,495.51 -718.94 4.73
Operating Margin - 5 Yr. Avg. -2,718.78 -596.41 6.40
Pre-Tax Margin (TTM) -4,367.83 -693.40 5.57
Pre-Tax Margin - 5 Yr. Avg. -2,028.72 -599.76 6.82
Net Profit Margin (TTM) -4,288.05 -694.62 1.87
Net Profit Margin - 5 Yr. Avg. -2,018.50 -602.62 3.09
Effective Tax Rate (TTM) -- 22.63 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.22 23.95

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 22,637,573 847,034,055
Net Income/Employee (TTM) -- 2,973,815 99,640,144
Receivable Turnover (TTM) 0.11 20.17 5.78
Inventory Turnover (TTM) -- 2.37 3.35
Asset Turnover (TTM) 0.01 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -29.88 -1.09 10.95
Return on Assets - 5 Yr. Avg. -34.24 -0.58 12.32
Return on Investment (TTM) -33.03 1.57 14.38
Return on Investment - 5 Yr. Avg. -38.70 2.21 16.11
Return on Equity (TTM) -36.01 2.43 16.07
Return on Equity - 5 Yr. Avg. -39.42 3.09 17.39
  1 Year 3 Year 5 Year
Sales % -38.66 42.12 -29.68
EPS (TTM) % 79.79 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Kazia Therapeutics Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 1.96%
# of Holders: 7
Total Shares Held: 94,647
3 Mo. Net Change: -356,660
# New Positions: 1
# Closed Positions: 1
# Increased Positions: 2
# Reduced Positions: 2
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.